Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$0.97 - $1.77 $43,650 - $79,650
-45,000 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$1.53 - $3.25 $30,600 - $65,000
-20,000 Reduced 30.77%
45,000 $80,000
Q4 2021

Feb 14, 2022

SELL
$2.68 - $4.46 $13,400 - $22,300
-5,000 Reduced 7.14%
65,000 $202,000
Q3 2021

Nov 15, 2021

BUY
$2.5 - $3.53 $175,000 - $247,100
70,000 New
70,000 $231,000

Others Institutions Holding CKPT

About Checkpoint Therapeutics, Inc.


  • Ticker CKPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 85,497,000
  • Market Cap $351M
  • Description
  • Checkpoint Therapeutics, Inc., clinical-stage immunotherapy and targeted oncology company, focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. The company's lead antibody product candidate is Cosibelimab, a fully-human monoclonal antibody of IgG1 subtype that directly binds to...
More about CKPT
Track This Portfolio

Track Telemetry Investments, L.L.C. Portfolio

Follow Telemetry Investments, L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Telemetry Investments, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Telemetry Investments, L.L.C. with notifications on news.